FORM OF STOCKHOLDER SUPPORT AGREEMENTStockholder Support Agreement • October 7th, 2019 • Innovate Biopharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Stockholder Support Agreement (this “Agreement”), dated as of October __, 2019, is by and between Innovate Biopharmaceuticals, Inc., a Delaware corporation (“Parent”), RDD Pharma, Ltd., an Israel corporation (the “Company”) and the undersigned (“Stockholder”).
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among: INNOVATE BIOPHARMACEUTICALS, INC., INNT MERGER SUB 1 LTD., RDD PHARMA LTD.Merger Agreement • October 7th, 2019 • Innovate Biopharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Form of Lock-Up Letter AgreementLock-Up Agreement • October 7th, 2019 • Innovate Biopharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
The undersigned, a holder of equity securities of Innovate Biopharmaceuticals, Inc. (“Parent”), desires that a company organized under the laws of Israel and a direct, wholly-owned subsidiary of the Parent merge (the “Merger”) with and into RDD Pharma, Ltd., company organized under the laws of Israel (“Company”) pursuant to an Agreement and Plan of Merger and Reorganization (the “Merger Agreement). For good and valuable consideration, the undersigned is entering into this agreement (this “Lock-Up Letter Agreement”) and hereby irrevocably agrees that following the closing of the Merger (the “Closing Date”), and until 180 days following the Closing Date (the “Lock-Up Period End Date”), the undersigned will not, directly or indirectly:
